Спайдер повышается перед открытием торгов на NYSE.
Европейские индексы на отрицательной территории.
SPY (внутридневной график) рост движение на премаркете. Сопротивление: 166.20 Поддержка: 165.80 Премаркет NYSE/NASDAQ: Gappingup:
In reaction to stong earnings/guidance/SSS data: ENVI +28.6%, FCEL +15.4%, SIGM +9.1%, DDC +2.1%, COST +1.3%, WAG +1.3%.
M&A news: KDN +21.3% (to be acquired by SKF for $35.50 per share), LPX +9.1% (to acquire Ainsworth for ~$1.1 bln, upgraded to Buy from Hold at Deutsche Bank, upgraded to Buy at DA Davidson), TI +8.1% (AT&T (T), American Movill (AMX), and Naguib Sawiris have approached key shareholders who want to exit stakes in TI, according to reports), BBRY +2.8% (following late spike on M&A speculation), ASTX +2.3% (Astex Pharma to be acquired by Otsuka Pharma for $8.50 per share in cash), VOD +1.8% (Dealbook discusses VZ's efforts to secure financing for Vodafone (VOD) deal), VZ +0.5%.
Select India related names showing strength: HDB +6.3%, IBN +6%, TTM +2.7%.
Other news: LOCM +39% (signs agreement with Microsoft (MSFT) to provide location-based local product data for Bing ), CLWT +18.7% (Reports Contract Awarded to PACT), MDXG +15.8% (following yesterday's sell-off; to hold conference call to discuss FDA 'Untitled Letter' and reiterate guidance on Thursday, September 5, 2013 at 11 am Eastern Time ), POZN +15.3% (POZEN and Sanofi (SNY) sign exclusive licence agreement for the commercialization of PA8140/PA32540 tablets in the U.S.), CHTP +6.8% (announces FDA Acceptance of NORTHERA (droxidopa) NDA Resubmission), IDCC +5.6% (related to ITC decision to review ruling in case against Nokia and other parties), HIMX +5.4% (target raised to $12 at Oppenheimer on better LCoS outlook), ALU +3.6% (reached an agreement with Telefonica, to become a reference supplier for its 4G LTE network in Spain), AU +2.3% (still checking), MRLN +2.1% (Declares Special Dividend of $2.00/share), NOK +1.9% (still checking, was resumed with an Equal-Weight at Morgan Stanley), CELG +1.5% (reports postive results from from Phase III study).
Analyst comments: OVAS +6.2% (initiated with and Outperform at Wedbush), GRPN +5.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley), YY +4.1% (upgraded to Outperform at Pacific Crest; tgt $52), ONB +2% (upgraded to Strong Buy from Outperform at Raymond James), SI +1.6% (upgraded to Overweight from Equal-Weight at Barclays), RIG +1.5% (upgraded to Outperform from Neutral at Credit Suisse), OMC +1.1% (upgraded to Buy from Neutral at Lazard), GMCR +0.9% ( tgt to $95 from $89 at Canaccord Genuity).
Gapping down:
In reaction to disappointing earnings/guidance/SSS: CONN -12.3%, NCS -11.7%, BV -10.2%, EXA -8.2%, (thinly traded), MIND -7.2%, TITN -5.1%, GEF -4.8%.
Other news: AGEN -33.8% (GlaxoSmithKline's (GSK) MAGE-A3 Cancer Immunotherapeutic Phase 3 study in melanoma misses first co-primary endpoint), CPRX -7.2% (Registration Statement filed for additional $2,612,336 aggregate maximum principal amount of common stock), LNKD -1.8% (prices 5,381,166 shares of Class A common stock at $223.00 per share), CCL -1% (cont weakness), GSK -1% ( independent analysis of the DERMAi study showed that the study did not meet its first co-primary endpoint).
Analyst comments: Z -2.5% (downgraded to Underweight from Equal-Weight at Morgan Stanley), E -1.0% (downgraded to Neutral from Buy at Nomura).
Уважаемые инвесторы,
Информируем вас о текущей ситуации, связанной с Группой «Русагро».
30 апреля 2026 года Заместитель Генерального прокурора Российской Федерации обратился в...
Апрель для команды МГКЛ получился очень насыщенным: форумы, конференции, встречи с инвесторами и десятки часов общения с рынком. В мае график будет спокойнее, но впереди одно из ключевых...
Самый интересный пост: что внутри портфелей у нашей команды + короткое объяснение по каждой позиции
Сегодня пришло время совершить квартальное раскрытие наших инвестиционных портфелей. Что внутри? ✅Состав портфелей каждого из наших аналитиков ✅Короткое мнение каждого аналитика по каждой...
Росстандарт утвердил новый предварительный национальный стандарт (ПНСТ 1056‑2026) для систем ИИ на автомобильном транспорте, контролирующих выбросы вредных веществ Росстандарт утвердил новый предварит...
Росстандарт утвердил новый предварительный национальный стандарт (ПНСТ 1056‑2026) для систем ИИ на автомобильном транспорте, контролирующих выбросы вредных веществ Росстандарт утвердил новый предварит...